BMRA (Biomerica) Company Cash Volume

biomerica.com - graphic logo of issuer BMRA

Despite severe pricing pressure in the rapid diagnostics sector, Biomerica, Inc. (BMRA) is implementing automated gastrointestinal analysis systems that eliminate manual labor. Business stability is supported by the company's own manufacturing plants in the US. Cash flow dynamics demonstrate the issuer's financial resilience, and 0.00 characterizes this valuation parameter, allowing investors to promptly monitor listing risks and the company's cash balance.

BMRA - Biomerica Inc. Company Cash on Hand over the range 07/04/2022 - 11/21/2026

Financial and market metric breakdowns for Biomerica (BMRA)

- stock value and consensus price forecast:
- cash availability and cash flow indicators:
Basic company analysis:BMRA Biomerica
Product sample of biomerica.com

For Biomerica, Inc. (BMRA), the cash reserves history on GURU.Markets serves as an indicator of operational viability. This metric aggregates liquid assets to determine the issuer's real-time solvency. Daily monitoring allows for the prompt capture of capital burn rates, bypassing the delays associated with quarterly reporting. The current cash volume is critical for scaling InFoods sales and expanding insurance coverage in the US. The stability of this indicator confirms financial resilience during the expansion of diagnostic systems.

Who Biomerica, Inc. competes with